AnBio Therapeutics
New York, US · Founded 2021 · Cayman Islands corporation
Founders & leadership
WX
Wei XuNamed on SEC filing
LZ
Lihua ZhengNamed on SEC filing
JW
Junyuan WangNamed on SEC filing
ZZ
Zhengwei ZhuNamed on SEC filing
X(
Xiaohang (Tony) TongNamed on SEC filing
BY
Bing YanNamed on SEC filing
TJ
Ting JiaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$60.9M disclosed across 1 round · 2021
▶$60.9MraisedOct 2021 · 13 investors · BiotechnologyRule 506(b)
▶$60.9MraisedOct 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei XuDirector
- Lihua ZhengExecutive Officer, Director
- Junyuan WangExecutive Officer, Director
- Zhengwei ZhuDirector
- Xiaohang (Tony) TongDirector
- Bing YanExecutive Officer, Director
- Ting JiaDirector
- Offering amount
- $60.9M
- Amount sold
- $60.9M
- Minimum investment
- $200K
- Finders' fees
- $1.8M
- First sale
- Sep 2021
- Incorporated
- Corporation, Cayman Islands, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AnBio Therapeutics raised?
- AnBio Therapeutics has disclosed $60.9M raised across 1 round.
- Where is AnBio Therapeutics headquartered?
- AnBio Therapeutics is headquartered in New York, US.